Supplemental Balance Sheet Information

6 Months Ended

Mar. 31, 2024

Balance Sheet Related Disclosures [Abstract]

Supplemental Balance Sheet Information

Supplemental Consolidated Balance Sheet Information

	March 31, 2024		September 30, 2023
Allowance for credit losses	$	9.6	$	10.1
Warranty reserves	$	37.2	$	35.8
Accumulated depreciation on property, plant, and equipment	$	256.0	$	226.7
Inventories, net:
Raw materials and components	$	276.0	$	285.2
Work in process	135.9		135.0
Finished goods	177.0		172.4
Total inventories, net	$	588.9	$	592.6
Other current liabilities:
Income tax payable	$	31.8	$	72.8
Other current liabilities	221.9		258.9
Total other current liabilities	$	253.7	$	331.7

The following table provides a reconciliation of cash and cash equivalents and restricted cash, reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:

	March 31, 2024		March 31, 2023
Cash and cash equivalents	$	224.4	$	315.1
Short-term restricted cash included in other current assets	0.8		0.8
Total cash and cash equivalents and restricted cash shown in the Consolidated Statements of Cash Flows	$	225.2	$	315.9

Supplier Finance Program

The Company has agreements with third-party financial institutions to facilitate supply chain finance (“SCF”) programs. The SCF programs allow qualifying suppliers to sell their receivables, on an invoice level at the selection of the supplier, from the Company to the financial institutions and negotiate their outstanding receivable arrangements and associated fees directly with the financial institutions. Hillenbrand is not party to the agreements between the supplier and the financial institutions. The supplier invoices that have been confirmed as valid under the SCF programs require payment in full by the financial institutions to the supplier by the original maturity date of the invoice, or discounted payment at an earlier date as agreed upon with the supplier. The Company’s obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by a supplier’s participation in the SCF programs.

All outstanding amounts related to suppliers participating in the SCF programs are recorded upon confirmation with the third-party financial institutions in trade accounts payable in the Consolidated Balance Sheets, and associated payments are included in cash used in operating activities in the Consolidated Statements of Cash Flows. The Company’s outstanding obligations included in trade accounts payable as of March 31, 2024 and September 30, 2023,  were $28.9 and $29.1, respectively.

Trade Receivables Financing

During the six months ended March 31, 2024, the Company executed an amendment of its trade receivables financing arrangement (as amended, the “Amended Arrangement”) with a financial institution. In accordance with ASC 869, Transfers and Servicing, this Amended Arrangement is deemed a true sale, as the Company retains no rights or interest and has no obligations with respect to the trade receivables. The Company had proceeds from the sale of trade receivables under the Amended Arrangement of $66.4 and $127.7, respectively, for the three and six months ended March 31, 2024 ($0.0 for the three and six months ended March 31, 2023). As of March 31, 2024 and September 30, 2023, trade receivables in the amount

of $28.8 and $0.0, respectively, were sold to the financial institution and are not reflected in the trade receivables in the Consolidated Balance Sheets.